Literature DB >> 12681445

FAK overexpression upregulates cyclin D3 and enhances cell proliferation via the PKC and PI3-kinase-Akt pathways.

Daisuke Yamamoto1, Yoshiko Sonoda, Maki Hasegawa, Megumi Funakoshi-Tago, Eriko Aizu-Yokota, Tadashi Kasahara.   

Abstract

We previously demonstrated that FAK-transfected HL-60 (HL-60/FAK) cells exhibit anti-apoptotic capacity. Here, we report that HL-60/FAK cells proliferate much faster than vector-transfected control (HL-60/Vect) cells with a 1.5-fold faster doubling time. This observation prompted us to investigate the mechanism of how HL-60/FAK cells augment cell proliferation. Since a protein kinase C (PKC) inhibitor, chelerythrine, or a PI3-kinase inhibitor, LY294002, suppressed cell proliferation effectively, both PKC and PI-3-kinase pathways are presumed to be involved in the cell proliferation. Among cyclins and CDKs, cyclin D3 expression was particularly prominent in the HL-60/FAK cells. Among PKC family, particularly PKCalpha, beta and eta isoforms were activated and directly associated with FAK in HL-60/FAK cells. We assumed that FAK activates PKC and PI3-kinase-Akt pathway, which resulted in marked induction of cyclin D3 expression and CDK activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681445     DOI: 10.1016/s0898-6568(02)00142-0

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  20 in total

1.  Virus-induced Ca2+ influx extends survival of west nile virus-infected cells.

Authors:  Svetlana V Scherbik; Margo A Brinton
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.

Authors:  Baotran Ho; Gretchen Olson; Sheila Figel; Irwin Gelman; William G Cance; Vita M Golubovskaya
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

3.  MGr1-Ag/37LRP promotes growth and proliferation of gastric cancer in vitro and in vivo.

Authors:  L Liu; L Sun; K Wu; Y Shi; Y Wang; Y Wang; N Zhang; H Zhang; H Zhang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

Review 4.  Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease.

Authors:  John Caltagarone; Zheng Jing; Robert Bowser
Journal:  Biochim Biophys Acta       Date:  2006-11-30

Review 5.  Neutrophil transmigration, focal adhesion kinase and endothelial barrier function.

Authors:  Sarah Y Yuan; Qiang Shen; Robert R Rigor; Mack H Wu
Journal:  Microvasc Res       Date:  2011-08-16       Impact factor: 3.514

6.  Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.

Authors:  Aimin Wang; Juan Ren; Christina P Wang; Vincent C Hascall
Journal:  J Biol Chem       Date:  2014-01-30       Impact factor: 5.157

7.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

8.  FAK Promotes Early Osteoprogenitor Cell Proliferation by Enhancing mTORC1 Signaling.

Authors:  Shuqun Qi; Xiumei Sun; Han Kyoung Choi; Jinfeng Yao; Li Wang; Guomin Wu; Yun He; Jian Pan; Jun-Lin Guan; Fei Liu
Journal:  J Bone Miner Res       Date:  2020-06-05       Impact factor: 6.741

9.  Focal adhesion kinase mediates the interferon-gamma-inducible GTPase-induced phosphatidylinositol 3-kinase/Akt survival pathway and further initiates a positive feedback loop of NF-kappaB activation.

Authors:  Zhen Liu; Huifang M Zhang; Ji Yuan; Travis Lim; Alhousseynou Sall; Gregory A Taylor; Decheng Yang
Journal:  Cell Microbiol       Date:  2008-04-28       Impact factor: 3.715

10.  A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts.

Authors:  Donghang Zheng; Vita Golubovskaya; Elena Kurenova; Cheng Wood; Nicole A Massoll; David Ostrov; William G Cance; Steven N Hochwald
Journal:  Mol Carcinog       Date:  2010-02       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.